CHF Solutions Expands European Distribution to Italy

 

April 17, 2018—CHF Solutions, Inc. announced further expansion into the European markets with the initiation of a new distribution agreement with TRX Italy, SrI, to distribute the company’s Aquadex FlexFlow system in Italy.

CHF Solutions is commercializing the Aquadex FlexFlow system for its Aquapheresis therapy. The Aquadex FlexFlow system is indicated for temporary (≤ 8 hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and for extended (> 8 hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization. All treatments must be administered by a health care provider, under physician prescription, both having undergone training in extracorporeal therapies.

The company noted that the World Health Organization found that there are more than twice as many acute decompensated heart failure patients in Western Europe than in the United States as result of a larger and older population base, along with higher smoking patterns.

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.